| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 12/30/2004 | US20040265974 Human chemokine polypeptides |
| 12/30/2004 | US20040265973 Immunoglobulins; Chinese hamster ovary cell lines; site-directed mutagenesis; improved pharmacokinetics and pharmacodynamics; side effect reduction |
| 12/30/2004 | US20040265972 Modified human chorionic gonadotropin (CG) for use in treatment and prevention of metabolic and reproductive diseases |
| 12/30/2004 | US20040265970 Nucleotide sequences comprising sequences coding alternatively spliced neuregulin for use in treating and diagnosing cell proliferative disorders |
| 12/30/2004 | US20040265966 Secreted and transmebrane polypeptides and nucleic acids encoding the same |
| 12/30/2004 | US20040265963 Inhibitory peptide for use in treatment and prevention of nervous system, connective tissue, autoimmune, inflammatory and cell proliferative disorders |
| 12/30/2004 | US20040265962 Staphylococcus aureus genes & polypeptides |
| 12/30/2004 | US20040265936 In gram-negative host cells; immunogenic epitopes from herpes virus; cytokines; interleukins; interferons; tumour necrosis factors; solid phase synthesis; homologous recombination |
| 12/30/2004 | US20040265935 Botulinum toxin a peptides and methods of predicting and reducing immunoresistance to botulinum toxin therapy |
| 12/30/2004 | US20040265934 Peptide nucleic acids; tuberculosis diagnosis; site-directed mutagenesis; kits; solid phase synthesis |
| 12/30/2004 | US20040265933 From Streptococcus pneumoniae; antigens, immunogens; shuttle vectors; vaccines; drug screening |
| 12/30/2004 | US20040265932 Detecting mRNA which translates into mammaglobin and mucin-like proteins, then detecting cDNA; isolated from Bacillus substilis; solid phase synthesis |
| 12/30/2004 | US20040265928 Drug screening; cancer diagnosis; host cells |
| 12/30/2004 | US20040265920 Sampling cerebrospinal fluid for antibodies; solid phase synthesis; immunoassay |
| 12/30/2004 | US20040265913 Tumor necrosis factors (TNF); humanized/chimeric monoclonal antibodies; fab fragments; hybridomas, host cells, Chinese Hamster Ovary cells |
| 12/30/2004 | US20040265908 use of purified metal binding protein, metallothionein from a brine shrimp (Artemia), to reduce the concentration of a metal in a substrate; bioremediation; pollution control |
| 12/30/2004 | US20040265906 Genetically encoded fluorescent reporters of kinase, methyltransferase, and acetyl-transferase activities |
| 12/30/2004 | US20040265898 C-type lectin transmembrane antigen expressed in human prostate cancer and uses thereof |
| 12/30/2004 | US20040265894 G-protein chemokine receptor; use in drug screening and diagnosis of conditions related to the underexpression of the G-protein coupled receptor polypeptides by detecting a mutation |
| 12/30/2004 | US20040265893 Synthetic DNA encoding an orange seapen-derived green fluorescent protein with codon preference of mammalian expression systems and biosensors |
| 12/30/2004 | US20040265891 use in diagnosis and treatment of cancer, neurodegenerative, or immune disorders; antibodies for immunoassays; drug screening |
| 12/30/2004 | US20040265890 a polypeptide of given amino acid sequence; use as drug target for gastrointestinal disorders; fusion proteins; diagnosis |
| 12/30/2004 | US20040265888 Binary encoded sequence tags |
| 12/30/2004 | US20040265882 Diabetes gene |
| 12/30/2004 | US20040265878 Polypeptides and polynucleotides "BASB040" from neisseria meningitidis and vaccine comprising said polypeptides and polynucleotides |
| 12/30/2004 | US20040265872 nucleotide sequences for polypeptides of the riboflavin specific deaminase family, "ribG"; drug target for use screening for antibacterials; vectors, host cells |
| 12/30/2004 | US20040265866 Receptor on the surface of activated T-cells: ACT-4 |
| 12/30/2004 | US20040265862 Screening method for genes of brewing yeast |
| 12/30/2004 | US20040265859 Calcium-activated chloride channel proteins and their use in anti-metastatic therapy |
| 12/30/2004 | US20040265857 Cloning gene or fragment thereof via hybridization probe; solid phase synthesis; plasmids; for treating mycosis |
| 12/30/2004 | US20040265854 Recombinant human SM-11044-binding receptor proteins exhibiting ligand-binding activities, and their uses |
| 12/30/2004 | US20040265852 Diangnosis and treatment of AUR1 and/or AUR2 related disorders |
| 12/30/2004 | US20040265848 Circovirus sequences associated with piglet weight loss disease (PWD) |
| 12/30/2004 | US20040265841 Analyzing mutations in Myosin Light Chain 2a; titin-related diseases; drug screening; animal models; knockout cells; transgenic zebrafish; antibodies |
| 12/30/2004 | US20040265839 Gene knockout; gene overexpression; liposomes; fusion proteins; immunoglobulins; FC fragments; glutathione S-transferase (GST) polypeptides |
| 12/30/2004 | US20040265837 As well as Paget's disease, neurological/neuromuscular diseases, nerve diseases, and/or psychotropic diseases; chloride channel modulators |
| 12/30/2004 | US20040265834 Antibodies; host cells; membrane proteins; for treatment of carcinoma, rheumatoid arthritis, asthma, kidney or testis related carcinoma, and neuron diseases |
| 12/30/2004 | US20040265824 Secreted and cell surface genes expressed in benign and malignant colorectal tumors |
| 12/30/2004 | US20040265819 Uricosuric regulating action using protein comprising an amino acid sequence represented by SEQ ID NO:1 or an amino acid sequence derived therefrom being capable of transporting uric acid and its analogs; cardiovascular disorders; gout; hypotensive agents; nucleotide sequences; antibodies; modulators |
| 12/30/2004 | US20040265818 Histidine phosphatase interacting protein with 180kd |
| 12/30/2004 | US20040265812 Of given sequence; use in determing prognosis and detecting neurological disease; kits |
| 12/30/2004 | US20040265809 Polypeptides derived from retinoic acid-related orphan receptor(ror) and their applications |
| 12/30/2004 | US20040265808 Genes involved in osteogenesis, and methods of use |
| 12/30/2004 | US20040265806 Position-independent and tissue specific expression of a transgene in milk of transgenic animals |
| 12/30/2004 | US20040265801 Immunoassays for anti-HCV antibodies |
| 12/30/2004 | US20040265799 Human-virus homologous sequences and uses thereof |
| 12/30/2004 | US20040265792 Agents for treatment of hcv and methods of use |
| 12/30/2004 | US20040265788 Screen for sodium channel modulators |
| 12/30/2004 | US20040265442 Treatment of fruits or vegetables with hypersensitive response elicitor to inhibit postharvest disease or desiccation |
| 12/30/2004 | US20040265342 Desensitizing a patient to polypeptide allergen by administering a peptide derived from allergen to induce a late phase response in an individual who possesses major histocompatibility complex Class II molecule; immunotherapy; vaccines |
| 12/30/2004 | US20040265341 Prevention of uveitis |
| 12/30/2004 | US20040265338 Contain large deletions; vaccines against dengue virus infection; structural proteins encapsulate said subgenomic replicon |
| 12/30/2004 | US20040265336 Multivalent vaccination using recombinant adenovirus |
| 12/30/2004 | US20040265334 Purified or isolated antibody that binds to said outer membrane proteins; accurate diagnosis of ehrlichiosis |
| 12/30/2004 | US20040265333 Outer membrane protein of Ehrlichia canis and Ehrlichia chaffeensis |
| 12/30/2004 | US20040265332 BASB029 polynucleotide(s) and polypeptides from Neisseria meningitidis |
| 12/30/2004 | US20040265331 BASB027 proteins and genes from moraxella catarrhalis, antigens, antibodies, and uses |
| 12/30/2004 | US20040265330 Novel compounds |
| 12/30/2004 | US20040265329 Administering siderophore receptor polypeptides and porins from gram negative microbes, preferably, lipopolysaccarhide for treating mastitis in a milk producing animal |
| 12/30/2004 | US20040265328 Identifying polypeptide antigens that bind to sera raised against commensal bacterial proteins |
| 12/30/2004 | US20040265326 Culturing respiratory syncytial virus on cells in a culture medium; separating grown virus from culture medium; solubilizing at least fusion (F) protein, attachment (G) protein and matrix (M) protein from the separated virus; coisolating ,copurifying solubilized RSV proteins; immunogenic |
| 12/30/2004 | US20040265325 Human cytomegalovirus antigens expressed in MVA and methods of use |
| 12/30/2004 | US20040265324 Recombinant MVA virus expressing dengue virus antigens, and the use thereof in vaccines |
| 12/30/2004 | US20040265321 A dimeric fusion protein having two identical polypeptide chains, each chain wtih an extracellular region of an activating Fc gamma R containing an Fc binding site, joined to a molecule that binds an Fc gamma Rn; dimeric fusion protein specifically binds an immune complex |
| 12/30/2004 | US20040265320 Administering a compound selected from 3-O-(3',3'-dimethylsuccinyl) betulinic acid, 3-O-(3',3'-dimethylsuccinyl) betulin, 3-O-(3',3'-dimethylglutaryl) betulin, 3-O-(3',3'-dimethylsuccinyl) dihydrobetulinic acid, 3-O-(3',3'-dimethylglutaryl) betulinic acid, (3',3'-dimethylglutaryl) dihydrobetulinic acid |
| 12/30/2004 | US20040265317 Methods and compositions useful for inhibition of angiogenesis |
| 12/30/2004 | US20040265316 An antibody which specifically binds to a Fhit (fragile histidine triad) protein or derivative |
| 12/30/2004 | US20040265314 Soluble CLCA-1 and antagonists to CLCA-1 |
| 12/30/2004 | US20040265310 Novel prostate-restricted gene expressed in prostate cancer |
| 12/30/2004 | US20040265308 Prevention and treatment of amyloidogenic disease |
| 12/30/2004 | US20040265306 Efficient inhibition of hiv-1 viral entry through a novel fusion protein including of cd4 |
| 12/30/2004 | US20040265300 Targeting cancer cell; induction or prevention of apoptosis in eukaryotic cells; a fusion peptide contains a viral apoptotic peptide and an antibody fragment; recombinant host cell comprising the vector, encoding chimeric polypeptide; bioassay monitoring apoptosis activity; drug target |
| 12/30/2004 | US20040265287 Myocardial grafts and cellular compositions useful for same |
| 12/30/2004 | US20040265284 Methods for enhanced virus-mediated DNA transfer using molecules with virus-and cell-binding domains |
| 12/30/2004 | US20040265283 Hepatocyte growth factor gene as an active therapeutic agent; biodrugs; Parkinson's disease, Alzheimer's disease, spinal cord injury, diabetic peripheral neuritis, and ischemic cerebrovascular disorders (cerebral infarction, cerebral haemorrhage) |
| 12/30/2004 | US20040265278 Moraxella catarrhalis antigen, corresponding gene and uses thereof |
| 12/30/2004 | US20040265275 Polypeptide |
| 12/30/2004 | US20040265273 gene therapy; nucleic acid sequence encoding an amino terminal fragment of urokinase that comprises and epidermal growth factor-like domain; antimetastasis; murine urokinase ATF expressed by tumor cells in an athymic murine model unexpectedly effectively inhibits tumorigenicity |
| 12/30/2004 | US20040265272 Mammalian cell-infecting virus vector encoding epitope-bound beta2m and utilization thereof |
| 12/30/2004 | US20040265269 Cysteine variants of granulocyte colony-stimulating factor |
| 12/30/2004 | US20040265230 Compositions and methods for diagnosing and treating colon cancers |
| 12/30/2004 | DE20221079U1 New expression vector for producing annexin V, useful as anticoagulant, includes kanamycin resistance gene, also Escherichia coli containing the vector |
| 12/30/2004 | DE10324447A1 Generierung künstlicher Bindungsproteine auf der Grundlage von Ubiquitin Generation of artificial binding proteins on the basis of ubiquitin |
| 12/30/2004 | CA2469140A1 Hcv regulated proteins |
| 12/29/2004 | WO2004113573A2 Methods and compositions for analysis of plant gene function |
| 12/29/2004 | WO2004113572A1 Composition for screening anti-hypertension drug comprising mammal tctp gene or its protein product, and method for screening anti-hypertension drug using said composition |
| 12/29/2004 | WO2004113560A1 In vivo test system for detecting hiv-protease activity |
| 12/29/2004 | WO2004113552A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 12/29/2004 | WO2004113547A2 Potent combinations of mrna transport elements |
| 12/29/2004 | WO2004113546A2 CASTANEA SATIVA MILL. GENES CODIFYING FOR ALLENE OXIDE CYCLASE, CYSTATIN, β-1,3-GLUCANASE AND THAUMATIN-LIKE PROTEIN AND THEIR USE |
| 12/29/2004 | WO2004113542A1 Methods and means for delaying seed shattering in plants |
| 12/29/2004 | WO2004113540A1 Expression of heterologous protein |
| 12/29/2004 | WO2004113539A2 Method for producing a recombinant protein of interest and protein thus produced |
| 12/29/2004 | WO2004113535A1 Synuclein mutant having anticoagulant effect |
| 12/29/2004 | WO2004113533A1 LIVER X RECEPTOR α SPLICING VARIANT PROTEIN, GENE CODING FOR THE SAME AND USE THEREOF |
| 12/29/2004 | WO2004113532A1 Protein for screening cytostatic agent, method of screening cytostatic agent and cytostatic agent |
| 12/29/2004 | WO2004113528A2 Isoforms of elf-5a: senescence-induced elf5a; wounding-induced elf-5a; growth elf-5a; and dhs |
| 12/29/2004 | WO2004113527A1 Gene involved in abscisic acid inactivation |
| 12/29/2004 | WO2004113523A1 Granzyme b/golgin-160 interaction inhibitor |
| 12/29/2004 | WO2004113520A2 Modulation of coffee flavour precursor levels in green coffee grains |